94. Sentinel node biopsy with superparamagnetic iron oxide (SPIO) in early breast cancer patients: 3 years follow up of the newly implemented method

2016 ◽  
Vol 42 (9) ◽  
pp. S105
Author(s):  
A. Kurylcio ◽  
T. Nowikiewicz ◽  
J. Mielko ◽  
W. Zegarski ◽  
W.P. Polkowski
Keyword(s):  
Breast Cancer ◽  
Iron Oxide ◽  
Sentinel Node ◽  
Cancer Patients ◽  
Sentinel Node Biopsy ◽  
Early Breast Cancer ◽  
Superparamagnetic Iron Oxide ◽  
Breast Cancer Patients ◽  
Node Biopsy

scholarly journals Platelet-Rich Plasma (PRP) in Breast Cancer Patients: An Application Analysis of 163 Sentinel Lymph Node Biopsies

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
C. Eichler ◽  
C. Baucks ◽  
J. Üner ◽  
C. Pahmeyer ◽  
D. Ratiu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Sentinel Node ◽  
Cancer Patients ◽  
Sentinel Node Biopsy ◽  
Platelet Rich Plasma ◽  
Distant Metastases ◽  
Complication Rates ◽  
Breast Cancer Patients ◽  
Node Biopsy

Introduction. Literature shows platelet-rich plasma (PRP) to improve overall outcomes in orthopedics, dermatology, ophthalmology, gynecology, and plastic surgery. Data on oncological patients is very limited. Only one publication is available on PRP in breast cancer patients. This work evaluated PRP in sentinel node biopsy procedures for breast cancer patients in terms of complication rates and oncological short-term follow-up. Methods. The evaluated PRP was ACP®, i.e., autologous conditioned plasma by Arthrex®. Between 2015 and 2018, 163 patients were offered to receive an ACP®/PRP injection in their lymph node biopsy site. Recruitment resulted in an approximate one-to-one ratio for analysis. Endpoints were major (revision) and minor (seroma, hematoma, and infection) complications rates as well as distant metastases, local recurrence, and overall survival. Median follow-up was 30 months. Results. Complication rates and oncological follow-up showed PRP to be applicable to use in a sentinel node biopsy scenario in breast cancer patients. There were 0 revisions in the ACP®/PRP group and 1.2% revisions in the control group (not significant). Oncological follow-up showed zero (0) distant metastases and local recurrences as well as a 100% 30-month overall survival. Conclusions. This is the first analysis of ACP®/PRP used in breast cancer patients in a sentinel node biopsy setting worldwide. PRP does not seem to increase rates of local recurrence within this 30-month follow-up time frame. Also, trend towards decreasing complication rates could be shown.

scholarly journals Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node

2020 ◽  
Vol 21 (6) ◽  
pp. 1631-1636
Author(s):  
Leyla Shojaee ◽  
Sheida Abedinnegad ◽  
Nahid Nafisi ◽  
Farshad Naghshvar ◽  
Gholamali Godazandeh ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Sentinel Node ◽  
Cancer Patients ◽  
Sentinel Node Biopsy ◽  
Early Breast Cancer ◽  
Axillary Node ◽  
Breast Cancer Patients ◽  
Node Biopsy

Axillary ultrasound scanning in the follow-up of breast cancer patients undergoing sentinel node biopsy

The Breast ◽  
2007 ◽  
Vol 16 (2) ◽  
pp. 190-196 ◽  
Author(s):  
Tommaso Susini ◽  
Jacopo Nori ◽  
Ermanno Vanzi ◽  
Lorenzo Livi ◽  
Silvia Pecchioni ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Sentinel Node ◽  
Cancer Patients ◽  
Sentinel Node Biopsy ◽  
Ultrasound Scanning ◽  
Breast Cancer Patients ◽  
Axillary Ultrasound ◽  
Node Biopsy

Axillary recurrences in early breast cancer patients treated with sentinel node biopsy. Experience at the Instituto Nacional de Enfermedades Neoplasicas.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e12068-e12068
Author(s):  
Jorge Antonio Dunstan ◽  
Carlos Castaneda Altamirano ◽  
Julio E. Abugattas Saba ◽  
Jose M. Cotrina ◽  
Franco F. Doimi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Sentinel Node ◽  
Cancer Patients ◽  
Sentinel Node Biopsy ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Node Biopsy
Sign in / Sign up

Export Citation Format

Share Document